1. Pink Sheet

UK Early Access Scheme 'A Success,' But Industry Wants Improvements

 
• By Leela Barham

Launched in April 2014, the UK’s Early Access to Medicines Scheme has delivered pre-approval patient access to many treatments for life-threatening and seriously debilitating conditions. But after 10 years of the EAMS, the pharmaceutical industry wants new guidance and says the scheme should evolve so that companies can make the most of the opportunity it offers in the future.

doctor prescribing medicine sitting at the desk in the clinic office
The EAMS has allowed early patient access to many new medicines • Source: Shutterstock

The Association of the British Pharmaceutical Industry has suggested that new guidance could help companies who want to take advantage of the UK’s Early Access to Medicines Scheme (EAMS) in the future, and says that it wants to help shape such guidance. 

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

More from Geography